Fu Shiow Yin
Director/Board Member at FORESEE PHARMACEUTICALS CO., LTD.
Profile
Fu Shiow Yin is an Independent Director at EirGenix, Inc., Foresee Pharmaceuticals Co., Ltd., and a Principal at Yao Hwa Glass Co. Ltd.
Management Committee.
Previously, she worked as a Director at TaiGen Biotechnology Co., Ltd.
and an Independent Director at Pac-Link Bio Venture Capital Investment Corp.
Dr. Yin holds a doctorate degree from the University of Rochester.
Fu Shiow Yin active positions
| Companies | Position | Start |
|---|---|---|
| FORESEE PHARMACEUTICALS CO., LTD. | Director/Board Member | 2016-03-30 |
| EIRGENIX INC. | Director/Board Member | - |
| Yao Hwa Glass Co. Ltd. Management Committee | Corporate Officer/Principal | - |
Former positions of Fu Shiow Yin
| Companies | Position | End |
|---|---|---|
| Pac-Link Bio Venture Capital Investment Corp. | Independent Dir/Board Member | - |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Director/Board Member | - |
Training of Fu Shiow Yin
| Rochester Christian University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EIRGENIX INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Private companies | 3 |
|---|---|
| Yao Hwa Glass Co. Ltd. Management Committee | |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
| Pac-Link Bio Venture Capital Investment Corp. |
- Stock Market
- Insiders
- Fu Shiow Yin
